title: A new era for Waldenstrom macroglobulinemia: MYD88 L265P.
abstract: In this issue of Blood, Poulain et al demonstrate the high prevalence of the MYD88 L265P somatic mutation in patients with Waldenstrom macroglobulinemia (WM) and provide insight into its biological relevance in the growth and survival of WM.
authors.affiliation: Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute.
authors.forename: Steven P
authors.initials: SP
authors.lastname: Treon
authors.forename: Zachary R
authors.initials: ZR
authors.lastname: Hunter
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D053594:Myeloid Differentiation Factor 88 / Q000235:genetics*; D017354:Point Mutation; D008258:Waldenstrom Macroglobulinemia / Q000235:genetics*
chemical_list: C507779:MYD88 protein, human; D053594:Myeloid Differentiation Factor 88